TY - JOUR
T1 - New approach for analyzing self-reporting of insomnia symptoms reveals a high rate of comorbid insomnia across a wide spectrum of chronic diseases
AU - Katic, Bozena
AU - Heywood, James
AU - Turek, Fred
AU - Chiauzzi, Emil
AU - Vaughan, Timothy E.
AU - Simacek, Kristina
AU - Wicks, Paul
AU - Jain, Sachin
AU - Winrow, Christopher
AU - Renger, John J.
N1 - Funding Information:
James Heywood, Bozena Katic, Emil Chiauzzi, Timothy E Vaughan, Kristina Simacek, and Paul Wicks are employees of PatientsLikeMe and hold stock/stock options. The PatientsLikeMe Research Team has received research funding (including conference support and consulting fees) from Abbvie, Accorda, Actelion, Amgen, AstraZeneca, Avanir, Biogen, Boehringer Ingelheim, Genzyme, Janssen, Johnson & Johnson, Merck, Novartis, Sanofi, and UCB. The PatientsLikeMe R&D team has received research grant funding from Kaiser Permanente, the Robert Wood Johnson Foundation, Sage Bionetworks, The AKU Society, and the University of Maryland. Paul Wicks has received speaker fees from Bayer. James Heywood has received speaker fees from multiple pharma companies and organizations including the DIA, and is Chairman and a significant shareholder of AOBiome which is developing a biome therapy that may have applications in sleep. Christopher Winrow and John Renger are current employees of Merck and hold stock/stock options. Sachin Jain is a former employee of Merck and holds stock/stock options. Fred Turek has served as a consultant and has received grant support from Merck for unrelated studies.
Funding Information:
This study was funded by Merck & Co., Inc. , Kenilworth, NJ. The sponsor reviewed a penultimate version of this paper but had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
Publisher Copyright:
© 2015 The Authors.
PY - 2015/11
Y1 - 2015/11
N2 - Background: Insomnia is increasingly recognized to be comorbid with one or more medical conditions. This study used an online research platform to characterize insomnia across different mental and physical conditions. Methods: A custom cross-sectional survey was fielded online to 31,208 users of the patient community PatientsLikeMe. The survey queried members on National Sleep Foundation-defined insomnia risk (waking up feeling unrefreshed, difficulty falling asleep, waking in the middle of the night, or waking too early). Results: Complete results were obtained from 5256 patients with 11 comorbid conditions. Seventy-six percent of US-based respondents were at risk for insomnia. Patients who reported difficulty falling asleep were found to have nearly twice the odds of self-reporting insomnia (odds ratio [OR]: 1.84; 95% confidence interval [CI]: 1.5-2.1) when compared to those who do not have difficulty falling asleep, whereas those who reported waking during the night or waking up unrefreshed were no more likely (OR: 1.025 and 1.032, respectively) to report that they suffered from insomnia than those who did not experience these issues. Although insomnia was self-reported as severe or very severe across most conditions, few respondents had actually been diagnosed with insomnia by a physician. After adjustment for age and gender, there was an independent and strong effect of primary condition severity on insomnia risk, and those with severe epilepsy (0.93), depressive disorders (0.92), and fibromyalgia (0.92) occupied the highest risk probabilities. Conclusions: The high rate of severity and frequency of insomnia across a multitude of mental and physical conditions reveals an opportunity for better disease management through enhanced insomnia awareness.
AB - Background: Insomnia is increasingly recognized to be comorbid with one or more medical conditions. This study used an online research platform to characterize insomnia across different mental and physical conditions. Methods: A custom cross-sectional survey was fielded online to 31,208 users of the patient community PatientsLikeMe. The survey queried members on National Sleep Foundation-defined insomnia risk (waking up feeling unrefreshed, difficulty falling asleep, waking in the middle of the night, or waking too early). Results: Complete results were obtained from 5256 patients with 11 comorbid conditions. Seventy-six percent of US-based respondents were at risk for insomnia. Patients who reported difficulty falling asleep were found to have nearly twice the odds of self-reporting insomnia (odds ratio [OR]: 1.84; 95% confidence interval [CI]: 1.5-2.1) when compared to those who do not have difficulty falling asleep, whereas those who reported waking during the night or waking up unrefreshed were no more likely (OR: 1.025 and 1.032, respectively) to report that they suffered from insomnia than those who did not experience these issues. Although insomnia was self-reported as severe or very severe across most conditions, few respondents had actually been diagnosed with insomnia by a physician. After adjustment for age and gender, there was an independent and strong effect of primary condition severity on insomnia risk, and those with severe epilepsy (0.93), depressive disorders (0.92), and fibromyalgia (0.92) occupied the highest risk probabilities. Conclusions: The high rate of severity and frequency of insomnia across a multitude of mental and physical conditions reveals an opportunity for better disease management through enhanced insomnia awareness.
KW - Chronic medical comorbidities
KW - Insomnia severity
KW - Online patient platform
KW - Sleep survey
UR - http://www.scopus.com/inward/record.url?scp=84944622681&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84944622681&partnerID=8YFLogxK
U2 - 10.1016/j.sleep.2015.07.024
DO - 10.1016/j.sleep.2015.07.024
M3 - Article
C2 - 26498232
AN - SCOPUS:84944622681
SN - 1389-9457
VL - 16
SP - 1332
EP - 1341
JO - Sleep Medicine
JF - Sleep Medicine
IS - 11
M1 - 2866
ER -